基本信息
浏览量:315
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
His main interests are clinical management of rare cancers, especially sarcomas and cancers of unknown primary site and methodology of early phase clinical trials. He is coordinator of numerous clinical trials assessing new drugs in rare cancers and urological cancers. Prof Penel is a member of the American Society of Clinical Oncology, the European Society for Medical Oncology and the French Society of Cancer.
Prof Penel is the author or co-author of over 240 publications in medical oncology.
Prof Penel is the author or co-author of over 240 publications in medical oncology.
研究兴趣
论文共 757 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Noemie Huchet,Nicolas Penel,Sylvie Bonvalot, Juliette Thariat,Francoise Ducimetiere,Antoine Giraud,Maud Toulmonde,Axel Le Cesne,Jean-Yves Blay,Carine Bellera
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2024): 17588359231220999-17588359231220999
Bulletin du cancerno. 2 (2024): 222-227
Jérémie Naffrichoux, Pierre Poupin, William Pouillot,Claude Linassier,Nathalie Rioux-Leclercq,Manon De Vries-Brilland,Loic Mourey,Brigitte Laguerre, Stéphane Oudard,Marine Gross-Goupil, Coralie Mousset,Gwenaëlle Gravis,
crossref(2024)
Estelle M.N. Laurent, Christophe Ducrocq,Pierre-Yves Cren, Khaled Boutaa, Dominique Crie,Nicolas Penel
Bulletin du Cancerno. 5 (2024): 505-512
Bulletin du Cancer (2024)
A. Le Cesne,S. Chabaud, O. Bouche,N. Penel,M. Brahmi,M. Toulmonde,E. Bompas,F. Bertucci,L. Chaigneau, W. Lahlou,B. Landi,B. Verret,
ESMO Open (2024)
Bulletin du cancer (2024)
J. Y. Blay, C. Tlemsani,M. Toulmonde,A. Italiano,M. Rios,E. Bompas, T. Valentin,F. Duffaud,L. R. Le Nail, S. Watson,N. Firmin,P. Dubray-Longeras,
J-Y. Blay, Q. Devin,F. Duffaud,M. Toulmonde,N. Firmin,O. Collard, E. Bompas,B. Verret,I.L. Ray-Coquard, S. Salas,C. Henon, C. Honoré,
ESMO Open (2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn